XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Awards (Tables)
6 Months Ended
Jun. 30, 2022
Stock-Based Awards  
Assumptions used to determine fair value of stock options granted

    

Six Months Ended

June 30, 

2022

2021

Risk-free interest rate

 

1.90

%

0.91

%

Expected term (in years)

 

6.2

6.2

Expected volatility

 

77.95

%

76.60

%

Expected dividend yield

 

0

%

0

%

Summary of stock option activity

    

    

    

Weighted

    

Weighted

Average

Average

Remaining

Aggregate

Number

Exercise

Contractual

Intrinsic

(In thousands, except share and per share data and years)

of Shares

Price

Term

Value

(in years)

Outstanding as of December 31, 2021

 

3,792,450

$

17.50

 

6.8

$

13,710

Granted

 

1,891,950

14.40

Exercised

 

(85,672)

1.40

1,115

Forfeited and cancelled

 

(583,775)

15.70

Outstanding as of June 30, 2022

 

5,014,953

$

16.81

 

7.1

$

10,817

Options vested and expected to vest as of June 30, 2022

 

5,014,953

$

16.81

 

7.1

$

10,817

Options exercisable as of June 30, 2022

 

2,519,499

$

18.26

 

4.8

$

7,784

Summary of restricted stock units activity

Weighted

Average

Grant Date

Aggregate

Number

Fair Value

Intrinsic

(In thousands, except share and per share data)

of Shares

Per Share

Value

Outstanding as of December 31, 2021

1,496,946

$

12.75

Granted

720,134

14.44

Vested

(513,958)

11.55

$

7,645

Forfeited and cancelled

(245,813)

12.17

Outstanding as of June 30, 2022

1,457,309

$

14.11

Stock-based compensation expense

Three Months Ended

Six Months Ended

June 30, 

June 30, 

(In thousands)

    

2022

    

2021

    

2022

    

2021

Cost of revenue

    

$

302

    

$

335

  

$

530

    

$

582

Research and development

941

1,154

828

2,030

General and administrative

 

2,449

 

2,343

 

4,680

 

3,895

Total stock-based compensation expense

$

3,692

$

3,832

$

6,038

$

6,507